Novant Health Bariatric Solutions - Greensboro

Novant Health Bariatric Solutions in Greensboro, North Carolina, operates as a multidisciplinary bariatric center within the Novant Health system, offering surgical weight loss procedures and comprehensive medical weight management programs for patients across the Piedmont Triad. The clinic addresses obesity-related conditions including type 2 diabetes, hypertension, sleep apnea, and metabolic syndrome through both surgical intervention and pharmacotherapy. Located in Greensboro, the center serves patients from Guilford County and surrounding areas including High Point, Winston-Salem, and Burlington with in-person consultations and follow-up care coordinated through the Novant Health network.

The surgical program includes laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, and revisional bariatric procedures performed by board-certified bariatric surgeons with fellowship training in metabolic and bariatric surgery. For patients who do not qualify for surgery or prefer medical management, the clinic provides GLP-1 receptor agonist therapies including semaglutide and tirzepatide as part of structured weight loss protocols. These peptide medications work by mimicking incretin hormones to regulate appetite, slow gastric emptying, and improve glycemic control in patients with obesity and prediabetes or diabetes. Treatment plans combine peptide therapy with nutritional counseling, exercise physiology guidance, and behavioral modification strategies tailored to individual metabolic profiles and weight loss goals.

The clinical team includes registered dietitians who provide pre-operative nutrition education and post-operative dietary progression protocols, ensuring patients meet protein and micronutrient requirements while adapting to reduced stomach capacity or altered nutrient absorption. Behavioral health specialists address emotional eating patterns, stress management, and psychological readiness for sustained lifestyle changes. Patients undergoing bariatric surgery complete mandatory pre-operative evaluations including metabolic testing, cardiac clearance, and nutrition assessments, followed by structured post-operative follow-up at intervals of two weeks, three months, six months, and annually to monitor weight loss progress, nutritional status, and resolution of comorbid conditions.

The patient pathway begins with an initial consultation where candidates undergo body composition analysis, review of medical history including previous weight loss attempts, and discussion of surgical versus medical management options based on BMI, comorbid conditions, and patient preference. Surgical candidates with BMI over 40 or BMI over 35 with obesity-related health conditions proceed through insurance authorization, pre-operative education classes, and multidisciplinary team evaluation. Medical weight management patients receive individualized peptide therapy protocols with dosage titration based on tolerance and response, combined with monthly monitoring visits to assess weight trends, side effect management, and adherence to dietary modifications. The Greensboro location coordinates care with Novant Health primary care providers and endocrinologists for patients requiring ongoing management of diabetes, thyroid disorders, or other metabolic conditions.

Novant Health Bariatric Solutions differentiates itself through integration with the larger Novant Health system, allowing seamless coordination of pre-operative testing, surgical procedures at Novant Health facilities in Greensboro, and post-operative care including access to physical therapy, cardiac rehabilitation, and specialty consults as needed. The program requires in-person visits for initial evaluations, surgical procedures, and critical follow-up appointments, though some nutritional counseling and behavioral health sessions may be conducted via telehealth for established patients. The clinic accepts most major insurance plans and assists patients with insurance verification and prior authorization processes for both surgical and peptide therapy coverage, recognizing that GLP-1 medications often require documentation of medical necessity and failed conservative weight loss attempts for approval.